About this product
Contains Dangerous Goods?No
Skin TypeAcne Prone
Ingredient PreferenceSalicylic acid
Pack TypeSingle Item
Quantity Per Pack1
Net Weight50g
Shelf Life24 Months
FDA Registration No.53-654313-997592
BrandGLOWGAZE
Product description
**Clinical Trial Report: Salicylic Acid Acne Removing Essence**
Testing Environment Parameters:
- Temperature-controlled laboratory: 22±2℃
- Relative humidity: 45%±5%
- Laboratory grade: ISO 14644-1 Class 7 dust-free environment
- Light source: Standard D65 illuminant
Randomized Double-Blind Controlled Trial (RDCT), conducted in accordance with ICH-GCP international clinical trial management standards, 42-day trial period.
Total 186 volunteers with acne-prone skin (age range: 16-35 years), including:
- Moderate acne: 76 subjects
- Severe acne: 18 subjects
- VISIA-CR Acne Analysis System
- Sebumeter SM 815 Sebum Measurement Device
- Mexameter MX 18 Melanin/Erythema Index Meter
- VC98 Multi-functional Skin Analyzer
- Confocal Laser Scanning Microscope
42-Day Clinical Observation Results:
- 4 subjects (2.15%) experienced temporary redness and tingling (Grade 1 reaction per Draize Scoring System)
- Skin tolerance test: 98.92% subjects showed good tolerance
- TEWL index fluctuation range: ±1.2g/m²/h (within safety parameters)
2. Acne Improvement (Based on KAGS Acne Grading System):
- Inflammatory Acne Improvement Rate:
- Non-inflammatory Acne Improvement Rate:
* Closed comedones: 85.6%
3. Skin Condition Improvement:
* T-zone oil secretion reduction: 43.8%
* Skin oil balance index improvement: 62.5%
* Pore size reduction: 32.7%
* Pore count reduction: 28.9%
- Inflammation Indicators:
* IL-1α inflammatory factor reduction: 56.3%
* Erythema index reduction: 47.2%
4. Post-Treatment Recovery:
- Post-inflammatory Hyperpigmentation Improvement:
* Superficial pigmentation: 65.8%
* Deep pigmentation: 41.3%
- Scarring prevention efficacy: 92.5%
- Skin texture improvement: 78.6%
5. Comprehensive Assessment:
- Product Safety: Compliant with CFDA, FDA, and KFDA standards
- Irritation Score: 0.76 (Draize Scoring System, 0-8 points)
- Overall Effectiveness Rate: 94.6%
- All testing procedures comply with ISO 9001:2015 quality management system
- SGS third-party certification obtained
- Compliant with EU Cosmetics Regulation (EC) No 1223/2009
1. Study approved by Medical Ethics Committee (IRB No.: 2023XK-789)
2. Compliant with Cosmetic Safety Assessment Technical Guidelines
3. Formula certified by International Nomenclature of Cosmetic Ingredients (INCI)
- Week 1: Baseline data establishment
- Weeks 2-4: Intensive monitoring period
- Weeks 5-6: Efficacy stability assessment
- 3-month post-trial: Long-term follow-up (50 subjects sampled)